197 related articles for article (PubMed ID: 24327585)
21. Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy.
Paulino AC; Mahajan A; Ye R; Grosshans DR; Fatih Okcu M; Su J; McAleer MF; McGovern S; Mangona VA; Chintagumpala M
Radiother Oncol; 2018 Jul; 128(1):128-132. PubMed ID: 29373195
[TBL] [Abstract][Full Text] [Related]
22. Hippocampal sparing approach in fractionated stereotactic brain VMAT radio therapy: A retrospective feasibility analysis.
Daniela Falco M; Giancaterino S; D'Andrea M; Gimenez De Lorenzo R; Trignani M; Caravatta L; Di Carlo C; Di Biase S; Allajbej A; Genovesi D
J Appl Clin Med Phys; 2018 Jan; 19(1):86-93. PubMed ID: 29125239
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
[TBL] [Abstract][Full Text] [Related]
24. Highly Conformal Craniospinal Radiotherapy Techniques Can Underdose the Cranial Clinical Target Volume if Leptomeningeal Extension through Skull Base Exit Foramina is not Contoured.
Noble DJ; Ajithkumar T; Lambert J; Gleeson I; Williams MV; Jefferies SJ
Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):439-447. PubMed ID: 28318880
[TBL] [Abstract][Full Text] [Related]
25. Intensity-modulated arc therapy for pediatric posterior fossa tumors.
Beltran C; Gray J; Merchant TE
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e299-304. PubMed ID: 21570213
[TBL] [Abstract][Full Text] [Related]
26. Preliminary results of conformal radiation therapy for medulloblastoma.
Merchant TE; Happersett L; Finlay JL; Leibel SA
Neuro Oncol; 1999 Jul; 1(3):177-87. PubMed ID: 11550312
[TBL] [Abstract][Full Text] [Related]
27. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.
Suzuki S; Kato T; Murakami M
J Radiat Res; 2021 Mar; 62(2):186-197. PubMed ID: 33341899
[TBL] [Abstract][Full Text] [Related]
28. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
Yock TI; Yeap BY; Ebb DH; Weyman E; Eaton BR; Sherry NA; Jones RM; MacDonald SM; Pulsifer MB; Lavally B; Abrams AN; Huang MS; Marcus KJ; Tarbell NJ
Lancet Oncol; 2016 Mar; 17(3):287-298. PubMed ID: 26830377
[TBL] [Abstract][Full Text] [Related]
29. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
30. Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study.
Mehta P; Janssen S; Fahlbusch FB; Schmid SM; Gebauer J; Cremers F; Ziemann C; Tartz M; Rades D
BMC Cancer; 2020 Jun; 20(1):610. PubMed ID: 32605648
[TBL] [Abstract][Full Text] [Related]
31. Association Between Brain Substructure Dose and Cognitive Outcomes in Children With Medulloblastoma Treated on SJMB03: A Step Toward Substructure-Informed Planning.
Acharya S; Guo Y; Patni T; Li Y; Wang C; Gargone M; Ashford JM; Wilson L; Faught A; Reddick WE; Patay Z; Gajjar A; Conklin HM; Merchant TE
J Clin Oncol; 2022 Jan; 40(1):83-95. PubMed ID: 34714708
[TBL] [Abstract][Full Text] [Related]
32. Life years lost--comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale.
Brodin NP; Vogelius IR; Maraldo MV; Munck af Rosenschöld P; Aznar MC; Kiil-Berthelsen A; Nilsson P; Björk-Eriksson T; Specht L; Bentzen SM
Cancer; 2012 Nov; 118(21):5432-40. PubMed ID: 22517408
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic conformal radiotherapy for posterior fossa tumours: a modelling study for potential improvement in therapeutic ratio.
Murthy V; Jalali R; Sarin R; Nehru RM; Deshpande D; Dinshaw KA
Radiother Oncol; 2003 May; 67(2):191-8. PubMed ID: 12812850
[TBL] [Abstract][Full Text] [Related]
34. Proton radiotherapy for high-risk pediatric neuroblastoma: early outcomes and dose comparison.
Hattangadi JA; Rombi B; Yock TI; Broussard G; Friedmann AM; Huang M; Chen YL; Lu HM; Kooy H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1015-22. PubMed ID: 22138463
[TBL] [Abstract][Full Text] [Related]
35. High-precision radiotherapy for craniospinal irradiation: evaluation of three-dimensional conformal radiotherapy, intensity-modulated radiation therapy and helical TomoTherapy.
Sharma DS; Gupta T; Jalali R; Master Z; Phurailatpam RD; Sarin R
Br J Radiol; 2009 Dec; 82(984):1000-9. PubMed ID: 19581313
[TBL] [Abstract][Full Text] [Related]
36. Development and evaluation of multiple isocentric volumetric modulated arc therapy technique for craniospinal axis radiotherapy planning.
Lee YK; Brooks CJ; Bedford JL; Warrington AP; Saran FH
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):1006-12. PubMed ID: 21345612
[TBL] [Abstract][Full Text] [Related]
37. Intensity-modulated radiotherapy for craniospinal irradiation: target volume considerations, dose constraints, and competing risks.
Parker W; Filion E; Roberge D; Freeman CR
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):251-7. PubMed ID: 17707279
[TBL] [Abstract][Full Text] [Related]
38. A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma.
Ho ESQ; Barrett SA; Mullaney LM
Acta Oncol; 2017 Aug; 56(8):1031-1042. PubMed ID: 28509599
[TBL] [Abstract][Full Text] [Related]
39. Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma.
Howell RM; Giebeler A; Koontz-Raisig W; Mahajan A; Etzel CJ; D'Amelio AM; Homann KL; Newhauser WD
Radiat Oncol; 2012 Jul; 7():116. PubMed ID: 22828073
[TBL] [Abstract][Full Text] [Related]
40. Ototoxicity evaluation in medulloblastoma patients treated with involved field boost using intensity-modulated radiation therapy (IMRT): a retrospective review.
Vieira WA; Weltman E; Chen MJ; da Silva NS; Cappellano AM; Pereira LD; Gonçalves MI; Ferrigno R; Hanriot RM; Nadalin W; Odone Filho V; Petrilli AS
Radiat Oncol; 2014 Jul; 9():158. PubMed ID: 25041714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
